D Daley1, R H Jacobsen2, A-M Lange3, A Sørensen4, J Walldorf4. 1. Division of Psychiatry and Applied Psychology, School of Medicine & Centre for ADHD and Neurodevelopmental Disorders across the Lifespan & NIHR MindTech Health Care Technology Cooperative, Institute of Mental Health, University of Nottingham, Nottingham, United Kingdom. Electronic address: david.daley@nottingham.ac.uk. 2. VIVE, The Danish Centre for Applied Social Science, Copenhagen, Denmark. 3. Aarhus University Hospital, Department of Child & Adolescent Psychiatry, Skejby, Denmark. 4. Department of Economics, Copenhagen Business School, Porcelaenshaven, Copenhagen, Denmark.
Abstract
AIM: Attention Deficit Hyperactivity Disorder (ADHD) is a lifespan disorder associated with considerable economic cost. While the economic burden of ADHD has been widely estimated, there is considerable variation in reported costs between studies, which typically focus on health outcomes only, lack adequate control and fail to correct for the influence of genetic and shared environmental factors. The aim of this study is to overcome these limitations to reach a fuller understanding of the economic burden of ADHD. METHOD: Using the Danish National Registers 5269 adults with a diagnosis of ADHD in adulthood who had not received a diagnosis in childhood were identified. Excluding cases with missing data, comorbid diagnoses, and cases without a same sex sibling free of any diagnosed psychiatric diagnoses, a final cohort was formed consisting of 460 sibling dyads. Using a cross-sectional method focusing on the year 2010, cost differences between each adult with ADHD and their sibling were calculated from data retrieved from health, education, crime, employment and social care registers. RESULTS: Adults with ADHD had considerably lower disposable income and paid less tax than their siblings. They also received more state benefits, had higher costs for health, social care, and crime than their siblings. The total average costs difference for the year 2010 was 20,134 euros more than their sibling for each adult with ADHD. CONCLUSION: ADHD is associated with considerable costs which are borne by both the individual and the state and underlines the need to consider the wider economic impact of ADHD beyond income and healthcare utilisation costs.
AIM: Attention Deficit Hyperactivity Disorder (ADHD) is a lifespan disorder associated with considerable economic cost. While the economic burden of ADHD has been widely estimated, there is considerable variation in reported costs between studies, which typically focus on health outcomes only, lack adequate control and fail to correct for the influence of genetic and shared environmental factors. The aim of this study is to overcome these limitations to reach a fuller understanding of the economic burden of ADHD. METHOD: Using the Danish National Registers 5269 adults with a diagnosis of ADHD in adulthood who had not received a diagnosis in childhood were identified. Excluding cases with missing data, comorbid diagnoses, and cases without a same sex sibling free of any diagnosed psychiatric diagnoses, a final cohort was formed consisting of 460 sibling dyads. Using a cross-sectional method focusing on the year 2010, cost differences between each adult with ADHD and their sibling were calculated from data retrieved from health, education, crime, employment and social care registers. RESULTS: Adults with ADHD had considerably lower disposable income and paid less tax than their siblings. They also received more state benefits, had higher costs for health, social care, and crime than their siblings. The total average costs difference for the year 2010 was 20,134 euros more than their sibling for each adult with ADHD. CONCLUSION:ADHD is associated with considerable costs which are borne by both the individual and the state and underlines the need to consider the wider economic impact of ADHD beyond income and healthcare utilisation costs.
Authors: Elizabeth M Kamai; Gro D Villanger; Rachel C Nethery; Cathrine Thomsen; Amrit K Sakhi; Samantha S M Drover; Jane A Hoppin; Gun Peggy Knudsen; Ted Reichborn-Kjennerud; Pål Zeiner; Kristin Overgaard; Amy H Herring; Heidi Aase; Stephanie M Engel Journal: Environ Epidemiol Date: 2021-07-01
Authors: Stephen V Faraone; Tobias Banaschewski; David Coghill; Yi Zheng; Joseph Biederman; Mark A Bellgrove; Jeffrey H Newcorn; Martin Gignac; Nouf M Al Saud; Iris Manor; Luis Augusto Rohde; Li Yang; Samuele Cortese; Doron Almagor; Mark A Stein; Turki H Albatti; Haya F Aljoudi; Mohammed M J Alqahtani; Philip Asherson; Lukoye Atwoli; Sven Bölte; Jan K Buitelaar; Cleo L Crunelle; David Daley; Søren Dalsgaard; Manfred Döpfner; Stacey Espinet; Michael Fitzgerald; Barbara Franke; Manfred Gerlach; Jan Haavik; Catharina A Hartman; Cynthia M Hartung; Stephen P Hinshaw; Pieter J Hoekstra; Chris Hollis; Scott H Kollins; J J Sandra Kooij; Jonna Kuntsi; Henrik Larsson; Tingyu Li; Jing Liu; Eugene Merzon; Gregory Mattingly; Paulo Mattos; Suzanne McCarthy; Amori Yee Mikami; Brooke S G Molina; Joel T Nigg; Diane Purper-Ouakil; Olayinka O Omigbodun; Guilherme V Polanczyk; Yehuda Pollak; Alison S Poulton; Ravi Philip Rajkumar; Andrew Reding; Andreas Reif; Katya Rubia; Julia Rucklidge; Marcel Romanos; J Antoni Ramos-Quiroga; Arnt Schellekens; Anouk Scheres; Renata Schoeman; Julie B Schweitzer; Henal Shah; Mary V Solanto; Edmund Sonuga-Barke; César Soutullo; Hans-Christoph Steinhausen; James M Swanson; Anita Thapar; Gail Tripp; Geurt van de Glind; Wim van den Brink; Saskia Van der Oord; Andre Venter; Benedetto Vitiello; Susanne Walitza; Yufeng Wang Journal: Neurosci Biobehav Rev Date: 2021-02-04 Impact factor: 9.052
Authors: Susan Young; Philip Asherson; Tony Lloyd; Michael Absoud; Muhammad Arif; William Andrew Colley; Samuele Cortese; Sally Cubbin; Nancy Doyle; Susan Dunn Morua; Philip Ferreira-Lay; Gisli Gudjonsson; Valerie Ivens; Christine Jarvis; Alexandra Lewis; Peter Mason; Tamsin Newlove-Delgado; Mark Pitts; Helen Read; Kobus van Rensburg; Bozhena Zoritch; Caroline Skirrow Journal: Front Psychiatry Date: 2021-03-19 Impact factor: 4.157
Authors: Søren D Østergaard; Betina B Trabjerg; Thomas D Als; Clara Albiñana Climent; Florian Privé; Bjarni Jóhann Vilhjálmsson; Marie Bækvad-Hansen; Jonas Bybjerg-Grauholm; David M Hougaard; Merete Nordentoft; Thomas Werge; Ditte Demontis; Preben B Mortensen; Anders D Børglum; Ole Mors; Esben Agerbo Journal: Transl Psychiatry Date: 2020-10-02 Impact factor: 6.222
Authors: Samuele Cortese; Cinzia Del Giovane; Samuel Chamberlain; Alexandra Philipsen; Susan Young; Andrea Bilbow; Andrea Cipriani Journal: BMJ Open Date: 2022-03-11 Impact factor: 2.692